Contemporary Drug Therapy for Renal Cell Carcinoma—Evidence Accumulation and Histological Implications in Treatment Strategy by Kazutoshi Yamana, Riuko Ohashi, Yoshihiko Tomita

Get full text

Acidic Microenvironment Enhances Cisplatin Resistance in Bladder Cancer via Bcl-2 and XIAP by Kaede Hiruma, Vladimir Bilim, Akira Kazama, Yuko Shirono, Masaki Murata, Yoshihiko Tomita

Get full text

MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma by Masaki Murata, Vladimir Bilim, Yuko Shirono, Akira Kazama, Kaede Hiruma, Masayuki Tasaki, Yoshihiko Tomita

Get full text

Postmarket safety communications on drugs approved in Japan: A 25‐year analysis by Yusuke Tanaka, Mototsugu Tanaka, Haruna Miyazawa, Ryohei Terashima, Makoto Miyazawa, Mutsuhiro Ikuma, Yoshihiko Tomita

Get full text

Urothelial carcinoma with sarcomatous variant of the bladder following radiotherapy for cervical cancer: A case report by Kohei Inui, Yuki Nakagawa, Go Hasegawa, Yohei Ikeda, Yo Sato, Tsutomu Nishiyama, Yoshihiko Tomita

Get full text

Perineal nuchal-type fibroma originated from perirectal region: A case report by Masaki Murata, Kohei Inui, Go Hasegawa, Yohei Ikeda, Yuki Nakagawa, Tsutomu Nishiyama, Yoshihiko Tomita

Get full text

Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells by Yuko Shirono, Vladimir Bilim, Tsutomu Anraku, Hiroo Kuroki, Akira Kazama, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita

Get full text

Long-term CMV monitoring and chronic rejection in renal transplant recipients by Shoko Ishikawa, Masayuki Tasaki, Kazuhide Saito, Yuki Nakagawa, Yuki Nakagawa, Masahiro Ikeda, Kota Takahashi, Yoshihiko Tomita

Get full text

Tumor-infiltrating immune cell status predicts successful response to immune checkpoint inhibitors in renal cell carcinoma by Akira Kazama, Vladimir Bilim, Masayuki Tasaki, Tsutomu Anraku, Hiroo Kuroki, Yuko Shirono, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita

Get full text

Achieving PSA < 0.2 ng/ml before Radiation Therapy Is a Strong Predictor of Treatment Success in Patients with High-Risk Locally Advanced Prostate Cancer by Akira Kazama, Toshihiro Saito, Keisuke Takeda, Kazuhiro Kobayashi, Toshiki Tanikawa, Ayae Kanemoto, Fumio Ayukawa, Yasuo Matsumoto, Tadashi Sugita, Noboru Hara, Yoshihiko Tomita

Get full text

Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II study by Yoshihiko Tomita, Hirotsugu Uemura, Mototsugu Oya, Nobuo Shinohara, Tomonori Habuchi, Yosuke Fujii, Yoichi Kamei, Yoshiko Umeyama, Angel H. Bair, Brian I. Rini

Get full text

Intraoperative intraocular pressure changes during robot-assisted radical prostatectomy: associations with perioperative and clinicopathological factors by Yuko Shirono, Itsuhiro Takizawa, Takashi Kasahara, Ryo Maruyama, Kazutoshi Yamana, Toshiki Tanikawa, Noboru Hara, Yuta Sakaue, Tetsuya Togano, Tsutomu Nishiyama, Takeo Fukuchi, Yoshihiko Tomita

Get full text

Long-term outcomes and prognostic factors of metastatic or recurrent pheochromocytoma and paraganglioma: a 20-year review in a single institution by Fumio Ishizaki, Takahiro Taguchi, Masaki Murata, Sayaka Hoshino, Tomotaka Toba, Keisuke Takeda, Masayuki Tasaki, Kazutoshi Yamana, Takashi Kasahara, Tatsuhiko Hoshii, Kenji Obara, Kazuhide Saito, Yoshihiko Tomita

Get full text

Hemostasis caused by stent-graft insertion followed by graft removal for pancreas graft bleeding due to chronic rejection: A case report by Kohei Miura, Takashi Kobayashi, Hirosuke Ishikawa, Seiji Saito, Yasuo Obata, Yohei Miura, Koji Toge, Yuki Hirose, Taku Ohashi, Kazuyasu Takizawa, Jun Sakata, Masayuki Tasaki, Kazuhide Saito, Yoshihiko Tomita, Toshifumi Wakai

Get full text

Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study by Masatoshi Eto, Toshio Takagi, Go Kimura, Satoshi Fukasawa, Satoshi Tamada, Yuji Miura, Mototsugu Oya, Naoto Sassa, Satoshi Anai, Masahiro Nozawa, Hideki Sakai, Rodolfo Perini, Wataru Yusa, Hiroki Ikezawa, Tomoyuki Narita, Yoshihiko Tomita

Get full text

Association between neutrophil-to-eosinophil ratio and efficacy outcomes with avelumab plus axitinib or sunitinib in patients with advanced renal cell carcinoma: post hoc analyses... by Brian Rini, Mariangela Mariani, Alessandra di Pietro, Paul Nathan, Christian Kollmannsberger, Marc-Oliver Grimm, Martin H Voss, Bradley A McGregor, Mehmet A Bilen, Yoshihiko Tomita, Bo Huang, Robert Amezquita, Matthew Tucker, Yu-Wei Chen

Get full text

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of C... by Thomas Powles, Laurence Albiges, David F McDermott, Michael B Atkins, Toni K Choueiri, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Martin H Voss, Hans J Hammers, Chung-Han Lee, Robert J Motzer, Yoshihiko Tomita, Nizar M Tannir, Meredith M Regan, Charlene M Mantia, Lisa Rosenblatt, Opeyemi A Jegede

Get full text

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random... by Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Viktor Grünwald, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir

Get full text